$0.03
(Market cap
$20 Mln
Recently Viewed
Clear AllMarket cap
$20 Mln
Revenue (TTM)
$38 Mln
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$-10 Mln
ROE
-0.2 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
0.5
Debt to Equity
0
Book Value
$2.5
EPS
$-0.4
Face value
--
Shares outstanding
29,937,159
CFO
$61.49 Mln
EBITDA
$101.08 Mln
Net Profit
$74.69 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Retractable Technologies (RVP)
| -14.8 | -10.1 | -7.6 | -4.9 | -29.0 | -42.4 | -11.6 |
|
BSE Sensex*
| -8.3 | 4.2 | -5.6 | -2.4 | 9.2 | 10.1 | 11.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Retractable Technologies (RVP)
| 11.9 | -37.7 | -32.3 | -76.3 | -35.5 | 616.0 | 152.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Retractable Technologies (RVP)
|
0.7 | 20.1 | 38.3 | -12.6 | -43.4 | -15.6 | -- | 0.3 |
| 8.3 | 5,633.8 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 1.0 | |
| 299.5 | 7,476.3 | 2,583.2 | 759.9 | 25.2 | 10.8 | 9.9 | 1.0 | |
| 39.7 | 6,195.5 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.4 | |
| 121.7 | 6,939.8 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 10.6 | |
| 82.9 | 5,456.9 | 1,541.6 | 233.6 | 21.6 | 21.4 | 24.6 | 5.0 | |
| 178.5 | 9,341.0 | 1,526.9 | -151.5 | 20.0 | -17.1 | 46.6 | 12.9 | |
| 332.2 | 12,941.2 | 1,403.7 | 177.7 | 14.7 | 13.8 | 73 | 9.1 | |
| 124.4 | 7,400.2 | 738.3 | 48.9 | 11.4 | 2.4 | 150.8 | 3.5 | |
| 32.7 | 14,139.4 | 6,178.4 | 626.5 | 13.0 | 11.9 | 23.2 | 2.6 |
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers... VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas. Read more
Founder, Chairman, President & CEO
Mr. Thomas J. Shaw
Founder, Chairman, President & CEO
Mr. Thomas J. Shaw
Headquarters
Little Elm, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Retractable Technologies Inc (RVP) is $0.66 (NYSE) as of 22-Apr-2026 16:10 EDT. Retractable Technologies Inc (RVP) has given a return of -28.96% in the last 3 years.
Since, TTM earnings of Retractable Technologies Inc (RVP) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-1.83
|
0.31
|
|
2024
|
-1.73
|
0.24
|
|
2023
|
-4.74
|
0.33
|
|
2022
|
9.67
|
0.46
|
|
2021
|
4.24
|
2.39
|
The 52-week high and low of Retractable Technologies Inc (RVP) are Rs 1.14 and Rs 0.60 as of 23-Apr-2026.
Retractable Technologies Inc (RVP) has a market capitalisation of $ 20 Mln as on 10-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Retractable Technologies Inc (RVP), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.